title: The dynamics of bone marrow stromal cells in the proliferation of multipotent hematopoietic progenitors by substance P: an understanding of the effects of a neurotransmitter on the differentiating hematopoietic stem cell.
abstract: Communication within the hematopoietic-neuroendocrine-immune axis is partly mediated by neurotransmitters (e.g. substance P, SP) and cytokines. SP mediates neuromodulation partly through the stimulation of bone marrow (BM) progenitors. This study shows that SP, through the neurokinin-1 receptor, stimulates the proliferation of primitive hematopoietic progenitors: cobblestone-forming cells (CAFC, CD34+). This effect is optimal when macrophage is included within the fibroblast support. Indirect induction of IL-1 could be important in the proliferation of CAFC colonies by SP. Phenotypic and functional studies suggest that SP might directly interact with the CD34+/CD45(dim) population. These studies indicate that SP can initiate a cascade of biological responses in the BM stroma and stem cells to stimulate hematopoiesis.
authors.affiliation: Department of Medicine-Hematology, UMDNJ-New Jersey Medical School, 185 South Orange Ave, MSB-Rm. E-585, Newark, NJ 07103, USA.
authors.forename: P
authors.initials: P
authors.lastname: Rameshwar
authors.forename: G
authors.initials: G
authors.lastname: Zhu
authors.forename: R J
authors.initials: RJ
authors.lastname: Donnelly
authors.forename: J
authors.initials: J
authors.lastname: Qian
authors.forename: H
authors.initials: H
authors.lastname: Ge
authors.forename: K R
authors.initials: KR
authors.lastname: Goldstein
authors.forename: T N
authors.initials: TN
authors.lastname: Denny
authors.forename: P
authors.initials: P
authors.lastname: Gascón
mesh_terms: D002454:Cell Differentiation / Q000187:drug effects / Q000276:immunology; D002455:Cell Division / Q000187:drug effects / Q000276:immunology; D002478:Cells, Cultured; D004357:Drug Synergism; D005472:Fluorouracil / Q000494:pharmacology; D015870:Gene Expression / Q000276:immunology; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007375:Interleukin-1 / Q000276:immunology; D007377:Interleukin-3 / Q000494:pharmacology; D015850:Interleukin-6 / Q000494:pharmacology; D008264:Macrophages / Q000166:cytology / Q000276:immunology; D015213:Neuroimmunomodulation / Q000502:physiology; D012333:RNA, Messenger / Q000032:analysis; D017472:Receptors, Interleukin-1 / Q000235:genetics; D018040:Receptors, Neurokinin-1 / Q000235:genetics; D018041:Receptors, Neurokinin-2 / Q000235:genetics; D019089:Stem Cell Factor / Q000494:pharmacology; D017154:Stromal Cells / Q000166:cytology* / Q000276:immunology*; D013373:Substance P / Q000494:pharmacology*
chemical_list: D007166:Immunosuppressive Agents; D007375:Interleukin-1; D007377:Interleukin-3; D015850:Interleukin-6; D012333:RNA, Messenger; D017472:Receptors, Interleukin-1; D018040:Receptors, Neurokinin-1; D018041:Receptors, Neurokinin-2; D019089:Stem Cell Factor; D013373:Substance P; D005472:Fluorouracil